Literature DB >> 10816347

Epidermal growth factor alters the bax:bcl-w ratio following massive small bowel resection.

L E Stern1, R A Falcone, F Huang, C J Kemp, C R Erwin, B W Warner.   

Abstract

BACKGROUND: Following massive small bowel resection (SBR), the expression of bax and bcl-w is associated with increased enterocyte apoptosis. Epidermal growth factor (EGF) has been shown to enhance enterocyte proliferation and retard apoptosis in the adapting bowel. This study examined the effect of EGF on the expression of these bcl-2 family members during adaptation.
MATERIALS AND METHODS: Mice (C57Bl/6; n = 38) underwent a 50% SBR or sham operation and then were randomized to receive twice-daily orogastric saline or EGF (50 microg/kg/day). After 3 days, the remnant ileum was removed, apoptotic index (No. apoptotic bodies/crypt) calculated, and expression of mRNA and protein for bax and bcl-w quantified.
RESULTS: EGF prevented the expected increase in the apoptotic index after SBR and altered the ratio of bax to bcl-w in favor of cell survival.
CONCLUSION: Following massive small bowel resection, EGF retards rates of enterocyte apoptosis and modifies the expression of bcl-2 family members. By decreasing bax and increasing bcl-w expression, the balance between pro- and anti-apoptotic genes is shifted in favor of cell survival. Alteration of bcl-2 family member expression may be an important mechanism by which EGF reduces the increased enterocyte apoptosis that occurs after massive small bowel resection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816347     DOI: 10.1006/jsre.2000.5897

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model.

Authors:  Hiroyuki Koga; Hua Yang; Emir Q Haxhija; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

2.  Influence of the site of small bowel resection on intestinal epithelial cell apoptosis.

Authors:  Emir Q Haxhija; Hua Yang; Ariel U Spencer; Xiaoyi Sun; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

Review 3.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

4.  Intestinal intraepithelial lymphocyte derived angiotensin converting enzyme modulates epithelial cell apoptosis.

Authors:  B E Wildhaber; H Yang; E Q Haxhija; A U Spencer; D H Teitelbaum
Journal:  Apoptosis       Date:  2005-12       Impact factor: 4.677

Review 5.  Growth factors: possible roles for clinical management of the short bowel syndrome.

Authors:  Mark E McMellen; Derek Wakeman; Shannon W Longshore; Lucas A McDuffie; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

6.  Adaptation: paradigm for the gut and an academic career.

Authors:  Brad W Warner
Journal:  J Pediatr Surg       Date:  2013-01       Impact factor: 2.545

7.  Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme.

Authors:  Emir Q Haxhija; Hua Yang; Ariel U Spencer; Hiroyuki Koga; Xiaoyi Sun; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-15       Impact factor: 4.052

Review 8.  BCL-w: apoptotic and non-apoptotic role in health and disease.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  Cell Death Dis       Date:  2020-04-21       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.